☆ 4.0 Article

Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma

ESOPHAGUS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

PD-L1 and PD-L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma

Kazuo Okadome et al.

Summary: This study investigated the impact of chemotherapy on PD-L1/L2 expression in esophageal squamous cell carcinoma, finding that preoperative chemotherapy may alter PD-L1 expression and that expression in primary lesions does not always match that of metastatic/recurrent lesions. The results suggest that a one-time evaluation is not sufficient to accurately assess PD-L1/L2 expression as a biomarker in esophageal cancer.

CANCER SCIENCE (2022)

添加到收藏夹

Meeting Abstract Oncology

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant

Ken Kato et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma

Joseph J. Zhao et al.

Summary: By reconstructing Kaplan-Meier plots of PD-L1 CPS subgroups, this study found no significant benefit in adding immune checkpoint inhibitors to chemotherapy for low PD-L1-expressing gastroesophageal adenocarcinoma tumors.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Y. Doki et al.

Summary: In patients with advanced esophageal squamous-cell carcinoma, both first-line treatment with nivolumab plus chemotherapy and first-line treatment with nivolumab plus ipilimumab resulted in significantly longer overall survival than chemotherapy alone, with no new safety signals identified.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Oncology

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer

Yong Jae Lee et al.

Summary: Neoadjuvant chemotherapy (NAC) induces changes in the tumor immune microenvironment (TIME), increasing immune infiltration and enhancing CD8 T cell activity. However, this increased immune activity does not translate into a survival benefit due to concomitant immunosuppression caused by an increase in regulatory T cells. These findings may help improve the effectiveness of immunotherapies in ovarian cancer.

CANCERS (2022)

添加到收藏夹

Article Cell Biology

Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma

Shota Sasagawa et al.

Summary: This study developed a machine-learning model to predict the response of esophageal squamous cell carcinoma (ESCC) to neoadjuvant chemotherapy (NAC) using whole-genome sequencing and RNA sequencing analysis. The study found that neutrophil infiltration and specific gene copy-number alterations are closely associated with NAC response.

CELL REPORTS MEDICINE (2022)

添加到收藏夹

Article Oncology

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden

Satoshi Muto et al.

Summary: In patients with non-small cell lung cancer, the expression of beta-catenin was negatively associated with the infiltration of CD11c(+) cells and cytotoxic T cells in tumor tissues, and correlated with a poorer prognosis.

ONCOLOGY LETTERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Cell Biology

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?

Imen Jridi et al.

Summary: Wnt proteins play crucial roles in development, cell fate specification, tissue regeneration, and tissue homeostasis, while aberrant Wnt signaling is associated with developmental defects, malignant transformation, inflammation, and cancer. Recent research suggests that dysregulated activation of Wnt signaling is involved in the pathogenesis of chronic inflammatory diseases, providing new insights for therapeutic interventions against inflammatory conditions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong-Mu Sun et al.

Summary: This study aimed to evaluate the antitumor activity of pembrolizumab plus chemotherapy versus chemotherapy alone as first-line treatment in advanced esophageal cancer. Results showed that pembrolizumab plus chemotherapy significantly improved overall survival and progression-free survival in patients with esophageal squamous cell carcinoma.

LANCET (2021)

添加到收藏夹

Article Oncology

Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer

Shani Ben Dori et al.

LUNG CANCER (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Comprehensive registry of esophageal cancer in Japan, 2012

Yuji Tachimori et al.

ESOPHAGUS (2019)

添加到收藏夹

Article Oncology

Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion

Hitomi Sakai et al.

LUNG CANCER (2019)

添加到收藏夹

Article Oncology

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus The Phase 2 KEYNOTE-180 Study

Manish A. Shah et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Review Immunology

WNT Signaling in Tumors: The Way to Evade Drugs and Immunity

Elena Martin-Orozco et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Epidemiology of Esophageal Squamous Cell Carcinoma

Christian C. Abnet et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis

Wei Guo et al.

Oncotarget (2018)

添加到收藏夹

Review Medicine, General & Internal

Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer A systematic review and meta-analysis

Xiangwei Zhang et al.

MEDICINE (2018)

添加到收藏夹

Article Immunology

Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Nicole Glodde et al.

IMMUNITY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice

Thomas W. Rice et al.

ANNALS OF CARDIOTHORACIC SURGERY (2017)

添加到收藏夹

Article Oncology

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

S. H. Lim et al.

EUROPEAN JOURNAL OF CANCER (2016)

添加到收藏夹

Article Oncology

Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery

Ken Hatogai et al.

JOURNAL OF SURGICAL ONCOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer

Jin Sheng et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Review Oncology

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

Lorenzo Galluzzi et al.

CANCER CELL (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.